About the Company
Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.) is an American-Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology. Bausch Health owns Bausch & Lomb, a supplier of eye health products. Bausch Health's business model is primarily focused on acquiring small pharmaceutical companies and then sharply increasing the prices of the drugs these companies sell. Valeant was originally founded in 1959, as ICN Pharmaceuticals by Milan Panić in California. During the 2010s, Valeant adopted a strategy of buying up other pharmaceutical companies which manufactured effective medications for a variety of medical problems, and then increasing the price of those medications. As a result, the company grew rapidly and in 2015 was the most valuable company in Canada. Valeant was involved in a number of controversies surrounding drug price hikes and the use of a specialty pharmacy for the distribution of its drugs. This led to an investigation by the U.S. Securities and Exchange Commission, causing its stock price to plummet more than 90 percent from its peak, while its debt surpassed $30 billion. In July 2018, the name of the company was changed to Bausch Health Companies Inc., in order to distance itself from the public outrage associated with massive price increases introduced by Valeant. At the same time, a new ticker symbol, BHC replaced VRX.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BHC News
Bausch Health Companies (NYSE: BHC)
Bausch Health Cos., Inc. engages in the development ... surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.
Bausch Health files patent lawsuit against Amneal Pharma for its liver disease drug
Bausch Health Companies Inc. along with its gastroenterology business, Salix Pharmaceuticals, Inc., has filed a lawsuit in the United States District Court against Amneal Pharmaceuticals. According to ...
Breakeven Is Near for Bausch Health Companies Inc. (NYSE:BHC)
With the business potentially at an important milestone, we thought we'd take a closer look at Bausch Health Companies Inc.'s (NYSE:BHC) future prospects. Bausch Health Companies Inc. operates as ...
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
LAVAL, QC / ACCESSWIRE / April 5, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) along with its gastroenterology business, Salix Pharmaceuticals, Inc., announced that it filed a lawsuit today ...
Bausch Health gets grant for drug delivery method using polyphosphazene-drug conjugates
Discover how Bausch Health's patented method using polyphosphazenes enhances drug delivery with high tumor selectivity and low toxicity.
Bausch Health Companies Inc.: Bausch Health to Announce First-Quarter 2024 Results on May 2
LAVAL, QC / ACCESSWIRE / April 11, 2024 / Bausch Health Companies Inc. (NYSE:NHC)(TSX:BHC) will release first-quarter 2024 financial results on Thursday, May 2, 2024. Bausch Health will host a confere ...
Bausch Health Companies Inc. (BHC)
LAVAL, QC / ACCESSWIRE / April 11, 2024 / Bausch Health Companies Inc. (NYSE:NHC)(TSX:BHC) will release first-quarter 2024 financial results on Thursday, May 2, 2024. Bausch Health will host a ...
Bausch Health Companies Inc
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop ...
Breakeven Is Near for Bausch Health Companies Inc. (NYSE:BHC)
With the business potentially at an important milestone, we thought we'd take a closer look at Bausch Health Companies Inc.'s (NYSE:BHC) future prospects. Bausch Health Companies Inc. operates as a ...
Bausch Health Companies Inc.: Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
LAVAL, QC / ACCESSWIRE / April 5, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) along with its gastroenterology business, Salix Pharmaceuticals, Inc., announced that it filed a lawsuit ...
Loading the latest forecasts...